Samir Tari

2.2k total citations · 2 hit papers
24 papers, 1.4k citations indexed

About

Samir Tari is a scholar working on Ophthalmology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Samir Tari has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 5 papers in Rheumatology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Samir Tari's work include Retinal Diseases and Treatments (11 papers), Ocular Diseases and Behçet’s Syndrome (11 papers) and Retinal and Optic Conditions (8 papers). Samir Tari is often cited by papers focused on Retinal Diseases and Treatments (11 papers), Ocular Diseases and Behçet’s Syndrome (11 papers) and Retinal and Optic Conditions (8 papers). Samir Tari collaborates with scholars based in United States, United Kingdom and Germany. Samir Tari's co-authors include Jennifer E. Thorne, Andrew D. Dick, Eric B. Suhler, Anne Camez, Alexandra Song, Martina Kron, Antoine P. Brézin, Glenn J. Jaffe, Nisha V. Kwatra and Martha Skup and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Samir Tari

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adalimumab in Patients with Active Noninfectious Uveitis

2016 418 citations Glenn J. Jaffe, Andrew D. Dick et al. New England Journal of Medicine profile →
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

2016 331 citations Quan Dong Nguyen, Pauline T. Merrill et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samir Tari United States	10	1.1k	390	208	166	148	24	1.4k
Marina Mesquida Spain	19	1.1k 0.9×	405 1.0×	174 0.8×	18 0.1×	101 0.7×	33	1.2k
Ryoji Yamakawa Japan	14	427 0.4×	75 0.2×	51 0.2×	95 0.6×	221 1.5×	54	679
Rossella Franceschini Italy	20	851 0.8×	504 1.3×	259 1.2×	8 0.0×	22 0.1×	48	1.1k
Levent Akduman United States	18	791 0.7×	83 0.2×	56 0.3×	19 0.1×	463 3.1×	83	933
June-Gone Kim South Korea	28	1.9k 1.7×	120 0.3×	98 0.5×	21 0.1×	1.2k 8.2×	94	2.1k
Ioannis Vergados Greece	21	868 0.8×	119 0.3×	27 0.1×	12 0.1×	542 3.7×	47	1.1k
Chaokui Wang China	17	436 0.4×	250 0.6×	54 0.3×	4 0.0×	25 0.2×	33	844
Xiongze Zhang China	18	852 0.8×	51 0.1×	14 0.1×	53 0.3×	391 2.6×	77	1.0k
Carol Wallace United Kingdom	12	262 0.2×	110 0.3×	28 0.1×	9 0.1×	44 0.3×	16	545
Rafael S. Grajewski Germany	15	489 0.4×	174 0.4×	43 0.2×	3 0.0×	46 0.3×	37	1.0k

Countries citing papers authored by Samir Tari

Since Specialization

Citations

This map shows the geographic impact of Samir Tari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Tari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Tari more than expected).

Fields of papers citing papers by Samir Tari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Tari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Tari. The network helps show where Samir Tari may publish in the future.

Co-authorship network of co-authors of Samir Tari

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Tari. A scholar is included among the top collaborators of Samir Tari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Tari. Samir Tari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suhler, Eric B., Jennifer E. Thorne, Manish Mittal, et al.. (2017). Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis. Ophthalmology. 124(12). 1799–1807. 28 indexed citations

Guo, Dianlin, et al.. (2017). Prevalence and Incidence of Optic Neuritis in Patients with Different Types of Uveitis. Ophthalmic Epidemiology. 25(1). 39–44. 4 indexed citations

Jaffe, Glenn J., Andrew D. Dick, Antoine P. Brézin, et al.. (2016). Adalimumab in Patients with Active Noninfectious Uveitis. New England Journal of Medicine. 375(10). 932–943. 418 indexed citations breakdown →

Nguyen, Quan Dong, Pauline T. Merrill, Glenn J. Jaffe, et al.. (2016). Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. The Lancet. 388(10050). 1183–1192. 331 indexed citations breakdown →

Suhler, Eric B., Glenn J. Jaffe, Quan Dong Nguyen, et al.. (2016). Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study. Arthritis & Rheumatism. 68. 1 indexed citations

Thorne, Jennifer E., Eric B. Suhler, Martha Skup, et al.. (2016). Prevalence of Noninfectious Uveitis in the United States. JAMA Ophthalmology. 134(11). 1237–1237. 172 indexed citations

Calster, Joachim Van, David K. Scales, Pablo Franco, et al.. (2015). Adalimumab in Patients with Active, Noninfectious Uveitis Using High-Dose Corticosteroids. UCL Discovery (University College London).

Sheppard, John D., Avani Joshi, Manish Mittal, et al.. (2015). Effect of adalimumab on visual functioning (VFQ-25) in VISUAL-1 trial patients with non-anterior non-infectious uveitis. Investigative Ophthalmology & Visual Science. 56(7). 1723–1723. 2 indexed citations

Jaffe, Glenn J., Jennifer E. Thorne, David K. Scales, et al.. (2015). Adalimumab in Patients With Active, Non-infectious Uveitis Requiring High-dose Corticosteroids: the VISUAL-1 Trial. Investigative Ophthalmology & Visual Science. 56(7). 3115–3115. 4 indexed citations

10.

Jaffe, Glenn J., Jennifer E. Thorne, David K. Scales, et al.. (2015). SAT0523 Adalimumab in Patients with Active, Non-Infectious Uveitis Requiring High-Dose Corticosteroids: the Visual-1 Trial. Annals of the Rheumatic Diseases. 74. 849–850. 6 indexed citations

11.

Tari, Samir, C. Michael Samson, Robert L. Harris, et al.. (2013). Polychromatic Angiography for the Assessment of VEGF-Induced BRB Dysfunction in the Rabbit Retina. Investigative Ophthalmology & Visual Science. 54(8). 5550–5550. 4 indexed citations

12.

Tari, Samir, et al.. (2012). Comparison of 1-Periodontal Indices and Cultural Porphyromonas Gingivalis Colony Count in Aggressive Periodontitis Patients Treated by Scaling and Rootplanning with or Without Metronidazole Gel. SHILAP Revista de lepidopterología. 4 indexed citations

13.

Tari, Samir, et al.. (2012). Comparison of 1-periodontal indices and cultural porphyromonas gingivalis colony count in aggressive periodontitis patients treated by scaling and rootplanning with or without metronidazole gel.. PubMed. 9(1). 50–8. 6 indexed citations

14.

Tari, Samir, et al.. (2007). FUNCTIONAL AND STRUCTURAL MEASUREMENTS FOR THE ASSESSMENT OF INTERNAL LIMITING MEMBRANE PEELING IN IDIOPATHIC MACULAR PUCKER. Retina. 27(5). 567–572. 45 indexed citations

15.

Hwang, Dah‐Ren, et al.. (2006). Retinal Function Assessment Following Intravitreal Injection of Erythropoietin in Rats: A Dose–Toxicity Study. Investigative Ophthalmology & Visual Science. 47(13). 5724–5724. 1 indexed citations

16.

Pachydaki, Sophia I., Samir Tari, Song Eun Lee, et al.. (2006). Upregulation of RAGE and its ligands in proliferative retinal disease. Experimental Eye Research. 82(5). 807–815. 76 indexed citations

17.

Ober, Michael D., et al.. (2006). Measurement of the Actual Dose of Triamcinolone Acetonide Delivered by Common Techniques of Intravitreal Injection. American Journal of Ophthalmology. 142(4). 597–600.e1. 15 indexed citations

18.

Hwang, J., et al.. (2005). Reproducibility of Eye Movement Compensated Fundus Perimetry. Investigative Ophthalmology & Visual Science. 46(13). 1561–1561. 1 indexed citations

19.

Avalle, Lucı́a B., James Dillon, Samir Tari, & Elizabeth R. Gaillard. (2005). A New Approach to Measuring the Action Spectrum for Singlet Oxygen Production by Human Retinal Lipofuscin. Photochemistry and Photobiology. 81(6). 1347–1350. 17 indexed citations

20.

Pachydaki, Sophia I., et al.. (2003). Induction of PVR in a Murine Model: Dispase-induced Disease Progresses in the Presence of a Retinal Tear. Investigative Ophthalmology & Visual Science. 44(13). 3010–3010. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact